IKT

insider transactions

Inhibikase Therapeutics, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Other·D
Feb 21, 26

Amit Munshi

Director

$0

19.1K sh

Own -33%
Other·D
Feb 21, 26

Christopher Cabell KEY

President & Head of R&D

$0

338.3K sh

Own -33%
Other·D
Feb 21, 26

Vincent Aurentz

Director

$0

255.3K sh

Own -33%
Grant·A
Jan 5, 26

Mark T Iwicki KEY

Chief Executive Officer

$0

5.0M sh

Own New
Grant·A
Jan 5, 26

David Mcintyre KEY

Chief Financial Officer

$0

986.3K sh

Own New
Grant·A
Jan 5, 26

Christopher Cabell KEY

President & Head of R&D

$0

900.1K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Feb 21, 2026	Amit Munshi	Director	Other D	19.1K	-33%	—	$0
Feb 21, 2026	Christopher Cabell KEY	President & Head of R&D	Other D	338.3K	-33%	—	$0
Feb 21, 2026	Vincent Aurentz	Director	Other D	255.3K	-33%	—	$0
Jan 5, 2026	Mark T Iwicki KEY	Chief Executive Officer	Grant A	5.0M	New	—	$0
Jan 5, 2026	David Mcintyre KEY	Chief Financial Officer	Grant A	986.3K	New	—	$0
Jan 5, 2026	Christopher Cabell KEY	President & Head of R&D	Grant A	900.1K	New	—	$0

About IKT insider trading

This page tracks insider transactions for Inhibikase Therapeutics, Inc. (IKT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.